Compare CPAY & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAY | ZBH |
|---|---|---|
| Founded | 1986 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 19.5B |
| IPO Year | 2010 | 2001 |
| Metric | CPAY | ZBH |
|---|---|---|
| Price | $329.51 | $92.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 19 |
| Target Price | ★ $378.91 | $105.17 |
| AVG Volume (30 Days) | 670.9K | ★ 2.0M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.05% |
| EPS Growth | ★ 7.59 | N/A |
| EPS | ★ 15.03 | 3.55 |
| Revenue | $4,528,403,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $18.85 | $4.93 |
| Revenue Next Year | $10.52 | $3.72 |
| P/E Ratio | ★ $21.91 | $25.93 |
| Revenue Growth | ★ 13.93 | 7.20 |
| 52 Week Low | $252.84 | $84.59 |
| 52 Week High | $361.99 | $114.44 |
| Indicator | CPAY | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 41.77 |
| Support Level | $317.38 | $89.38 |
| Resistance Level | $338.47 | $95.33 |
| Average True Range (ATR) | 12.65 | 2.25 |
| MACD | -2.11 | -0.99 |
| Stochastic Oscillator | 44.34 | 13.09 |
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.